ADM Patient Assessment & Clinical Evaluation 3

Question 1

A 28-year-old pregnant woman presents for addiction evaluation. Which screening tool is validated and recommended for substance use during pregnancy?

Accepted Answer

4Ps Plus

Answer

The 4Ps Plus screen (Parents, Partner, Past, Pregnancy) is validated for identifying substance use risk in pregnant women.

Question 2

Which component of the biopsychosocial assessment addresses a patient's trauma history and its relationship to substance use?

Accepted Answer

Psychosocial history

Answer

Trauma history is captured in the psychosocial history component, which explores adverse life events and their connection to substance use initiation and maintenance.

Question 3

During motivational interviewing-based assessment, the clinician notices the patient is ambivalent about stopping cannabis use. The BEST next step is to:

Accepted Answer

Explore the patient's pros and cons of use using a decisional balance

Answer

Exploring ambivalence through a decisional balance is a core MI technique that elicits the patient's own reasons for change.

Question 4

Which finding on urine drug screen would suggest benzodiazepine use not disclosed by the patient?

Accepted Answer

Positive for oxazepam and temazepam metabolites

Answer

Oxazepam and temazepam are benzodiazepine metabolites that appear in urine; their presence without a prescription suggests undisclosed use.

Question 5

Which co-occurring psychiatric disorder is MOST commonly associated with stimulant use disorder and should be assessed at intake?

Accepted Answer

ADHD and mood disorders

Answer

ADHD and mood disorders, particularly depression and bipolar disorder, are highly prevalent among patients with stimulant use disorder.

(ADM) Board Certified Addiction Medicine Specialist Practice Test

(ADM) Board Certified Addiction Medicine Specialist Practice Test

ADM Patient Assessment & Clinical Evaluation 3